Apogee Therapeutics Inc. (NASDAQ:APGE) is a top healthcare stock with high potential. Analyst Julian Harrison maintains a Buy rating, citing optimism in the company's APG777 treatment for asthma and dermatitis. Positive clinical data indicates significant upside potential.